Lanka Realty Investments Valuation
Is ASCO.N0000 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ASCO.N0000 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ASCO.N0000 (LKR11.2) is trading above our estimate of fair value (LKR0.7)
Significantly Below Fair Value: ASCO.N0000 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ASCO.N0000?
Other financial metrics that can be useful for relative valuation.
What is ASCO.N0000's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | LK₨2.37b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 8.3x |
Enterprise Value/EBITDA | -51.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ASCO.N0000's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7x | ||
ONAL.N0000 On'ally Holdings | 8.1x | n/a | LK₨2.3b |
CTLD.N0000 CT Land Development | 4.6x | n/a | LK₨2.0b |
CSD.N0000 Seylan Developments | 5.8x | n/a | LK₨2.3b |
EAST.N0000 East West Properties | 9.5x | n/a | LK₨1.2b |
ASCO.N0000 Lanka Realty Investments | 2.3x | n/a | LK₨2.4b |
Price-To-Sales vs Peers: ASCO.N0000 is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (7x).
Price to Earnings Ratio vs Industry
How does ASCO.N0000's PE Ratio compare vs other companies in the Asian Real Estate Industry?
Price-To-Sales vs Industry: ASCO.N0000 is good value based on its Price-To-Sales Ratio (2.3x) compared to the Asian Real Estate industry average (2.4x).
Price to Sales Ratio vs Fair Ratio
What is ASCO.N0000's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 2.3x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ASCO.N0000's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.